Compositions and methods for treating human papillomavirus-mediated disease

Details for Australian Patent Application No. 2003284239 (hide)

International Classifications

Event Publications

25 March 2004 Complete Application Filed

Priority application(s): 60/471,481 15.05.03 US; 60/420,068 21.10.02 US

17 June 2004 Application Open to Public Inspection

Published as AU-B-2003284239

21 August 2008 Application Accepted

Published as AU-B-2003284239

18 December 2008 Standard Patent Sealed

30 April 2009 Assignment Registered

MGI Pharma Biologics, Inc. The patent has been assigned to Eisai Corporation of North America

29 October 2009 Assignment Registered

Eisai Corporation of North America The patent has been assigned to Eisai Inc.

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.